The Department of Justice’s Antitrust Division today announced a settlement that would allow CVS Health and Aetna to proceed with their proposed merger if Aetna divests its Medicare Part D prescription drug plans to WellCare. The settlement was filed in federal court as part of a civil antitrust lawsuit brought by the department and state attorneys general from California, Florida, Hawaii, Mississippi and Washington over competitive concerns with the merger. If approved by the court, the settlement would resolve those concerns, the agency said.

Related News Articles

Headline
The AHA submitted a statement July 11 for a Senate Special Committee on Aging hearing on health care transparency and lowering health care costs. The AHA…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The Healthcare Equality Network July 3 sent a letter to the Centers for Medicare & Medicaid Services, expressing concerns about claims denials by…
Headline
The Department of Health and Human Services’ Office of Inspector General last week announced its intent to investigate Medicare Advantage Organizations’ prior…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
The Centers for Medicare & Medicaid Services June 28 released a proposed rule on mitigating the impact of significant, anomalous and highly suspect (SAHS)…